SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-21-000215
Filing Date
2021-11-15
Accepted
2021-11-15 07:30:48
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kprx-20210930x10q.htm   iXBRL 10-Q 1513777
2 EX-31.1 kprx-20210930xex31d1.htm EX-31.1 9562
3 EX-31.2 kprx-20210930xex31d2.htm EX-31.2 9533
4 EX-32.1 kprx-20210930xex32d1.htm EX-32.1 5227
5 EX-32.2 kprx-20210930xex32d2.htm EX-32.2 5444
  Complete submission text file 0001410578-21-000215.txt   6216241

Data Files

Seq Description Document Type Size
6 EX-101.SCH kprx-20210930.xsd EX-101.SCH 48495
7 EX-101.CAL kprx-20210930_cal.xml EX-101.CAL 45489
8 EX-101.DEF kprx-20210930_def.xml EX-101.DEF 217084
9 EX-101.LAB kprx-20210930_lab.xml EX-101.LAB 450608
10 EX-101.PRE kprx-20210930_pre.xml EX-101.PRE 341466
11 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20210930x10q_htm.xml XML 929199
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 211406335
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences